Table 3.
Years | Organization | LMWH | UFH | Timing | Grade |
---|---|---|---|---|---|
2012 | ACCP [26] | √ | √ | 2–4 days | Weak recommendation, low-quality evidence |
2014 | ESO [27] | Not mentioned | Not mentioned | Not mentioned | Weak recommendation, low-quality evidence |
2015 | AHA/ASA [28] | √ | √ | Not mentioned | Weak recommendation, moderate-quality evidence |
2016 | NCS [29] | √ | √ | Within 48 h | Weak recommendation, low-quality evidence |
2020 | HSFC [31] | √ | Not mentioned | After 48 h | Moderate-quality evidence |
ACCP the American College of Chest Physicians; ESO European Stroke Organization; AHS/ASA the American Heart Association/American Stroke Association; NCS the Neurocritical Care Society; HSFC Heart and Stroke Foundation of Canada; UFH unfractionated heparin; LMWH low molecular weight heparin
√ recommended, × not recommended